2.8K
Downloads
39
Episodes
The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment, mesothelioma science, the patient and caregiver experience and quality of life.
Episodes
Thursday Sep 30, 2021
Pneumonitis in immunotherapy-treated mesothelioma patients
Thursday Sep 30, 2021
Thursday Sep 30, 2021
Pneumonitis is a serious treatment-related side effect of both radiation, immunotherapy and some chemotherapies. This episode of MesoTV includes discussion on diagnosis, treatment and the dilemma facing both patients and doctors while making decisions on how to approach mesothelioma specific therapy during and post treatment for this condition. Dr. Daniel Sterman is a member of the Board of Directors at the Mesothelioma Applied Research Foundation. He is also Director of Pulmonary, Critical Care and Sleep Medicine at NYU Langone Medical Center. More information about MesoTV is available at www.curemeso.org/mesotv. More information about the Mesothelioma Applied Research Foundation can be found at www.curemeso.org.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.